Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Financing Activities (2016 - 2025)

Fortress Biotech has reported Cash from Financing Activities over the past 13 years, most recently at $5.7 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $5.7 million for Q4 2025, down 77.88% from a year ago — trailing twelve months through Dec 2025 was $77.4 million (up 9.63% YoY), and the annual figure for FY2025 was $77.4 million, up 9.63%.
  • Cash from Financing Activities for Q4 2025 was $5.7 million at Fortress Biotech, down from $15.1 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for FBIO hit a ceiling of $78.7 million in Q1 2021 and a floor of -$30.4 million in Q2 2023.
  • Median Cash from Financing Activities over the past 5 years was $16.8 million (2022), compared with a mean of $20.3 million.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 1115.75% in 2023 and later skyrocketed 455.96% in 2025.
  • Fortress Biotech's Cash from Financing Activities stood at $38.9 million in 2021, then plummeted by 52.19% to $18.6 million in 2022, then skyrocketed by 134.28% to $43.6 million in 2023, then crashed by 40.84% to $25.8 million in 2024, then crashed by 77.88% to $5.7 million in 2025.
  • The last three reported values for Cash from Financing Activities were $5.7 million (Q4 2025), $15.1 million (Q3 2025), and $4.5 million (Q2 2025) per Business Quant data.